Related Experiment Video
Updated: Dec 5, 2025

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells
Manon Penco-Campillo1, Yannick Comoglio1, Álvaro Javier Feliz Morel1
1Université Côte d'Azur, Institute for Research on Cancer and Ageing of Nice (IRCAN), CNRS UMR7284, INSERM U1081, Fédération Claude Lalanne (FCL), Nice, France.
Abstract:
Medulloblastoma (MB), the most common brain pediatric tumor, is a pathology composed of four molecular subgroups. Despite a multimodal treatment, 30% of the patients eventually relapse, with the fatal appearance of metastases within 5 years. The major actors of metastatic dissemination are the lymphatic vessel growth factor, VEGFC, and its receptors/co-receptors. Here, we show that VEGFC is inversely correlated to cell aggressiveness. Indeed, VEGFC decreases MB cell proliferation and migration, and their ability to form pseudo-vessel in vitro. Irradiation resistant-cells, which present high levels of VEGFC, lose the ability to migrate and to form vessel-like structures. Thus, irradiation reduces MB cell aggressiveness via a VEGFC-dependent process. Cells intrinsically or ectopically overexpressing VEGFC and irradiation-resistant cells form smaller experimental tumors in nude mice. Opposite to the common dogma, our results give strong arguments in favor of VEGFC as a negative regulator of MB growth.
Insights
Vascular Endothelial Growth Factor C (VEGFC) surprisingly inhibits medulloblastoma (MB) cell aggressiveness and tumor growth. This finding challenges previous notions and suggests VEGFC as a potential therapeutic target for pediatric brain tumors.
Area of Science:
- Oncology
- Molecular Biology
- Pediatric Neuro-oncology
Background:
- Medulloblastoma (MB) is the most common pediatric brain tumor, with a 30% relapse rate within 5 years.
- Metastatic dissemination in MB is linked to vascular endothelial growth factor C (VEGFC) and its receptors.
- Current treatment strategies for MB have limitations, necessitating novel therapeutic targets.
Purpose of the Study:
- To investigate the role of VEGFC in medulloblastoma cell aggressiveness and metastatic potential.
- To determine if VEGFC acts as a positive or negative regulator of MB growth and dissemination.
- To explore the VEGFC-dependent mechanisms underlying irradiation resistance in MB cells.
Main Methods:
- Analysis of VEGFC expression correlation with MB cell proliferation and migration.
- In vitro assessment of pseudo-vessel formation in MB cells.
- Evaluation of VEGFC levels in irradiation-resistant MB cells.
- Tumorigenicity assays in nude mice using MB cells with altered VEGFC expression.
Main Results:
- VEGFC expression is inversely correlated with medulloblastoma cell aggressiveness, decreasing proliferation and migration.
- Overexpression of VEGFC, observed in irradiation-resistant cells, impairs MB cell migration and pseudo-vessel formation.
- MB cells overexpressing VEGFC or exhibiting irradiation resistance formed smaller tumors in vivo.
- Irradiation reduces MB cell aggressiveness through a VEGFC-dependent pathway.
Conclusions:
- VEGFC acts as a negative regulator of medulloblastoma growth and metastatic potential, contrary to established beliefs.
- VEGFC-mediated inhibition of cell migration and proliferation offers a novel therapeutic avenue for MB.
- Targeting VEGFC pathways may enhance treatment efficacy and reduce relapse rates in pediatric medulloblastoma.
Related Concept Videos
Cells Coordinate Growth and Proliferation
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Hedgehog Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Abnormal Proliferation

